| 000 | 01802cam a2200349 a 4500 | ||
|---|---|---|---|
| 003 | EG-GiCUC | ||
| 005 | 20250223030731.0 | ||
| 008 | 121230s2012 ua dh f m 000 0 eng d | ||
| 040 |
_aEG-GiCUC _beng _cEG-GiCUC |
||
| 041 | 0 | _aeng | |
| 049 | _aDeposite | ||
| 097 | _aPh.D | ||
| 099 | _aCai01.19.06.Ph.D.2012.Re.H | ||
| 100 | 0 | _aReem Mohamed Emad Eldin | |
| 245 | 1 | 0 |
_aHypofractionated stereotactic radiation treatment for benign perioptic tumors / _cReem Mohamed Emad Eldin ; Supervised Hoda Mohamed Abdulbaki , Tarek Hamed Shouman , Wael Abdulhalim Reda |
| 246 | 1 | 5 | _aالعلاج الإشعاعى المجسم ثلاثي الأبعاد (ستيريوتاكتك) ذو التجزئة المنخفضة للأورام الحميدة حول الجهاز البصري |
| 260 |
_aCairo : _bReem Mohamed Emad Eldin , _c2012 |
||
| 300 |
_a120 P. : _bcharts , facsimiles ; _c25cm |
||
| 502 | _aThesis (Ph.D.) - Cairo University - National Cancer Institute - Department of Radiation-Oncology | ||
| 520 | _aThis prospective one arm clinical trial aimed to evaluate the use of hypofractionated stereotactic radiotherapy for benign perioptic tumors and the preservation of visual field and pituitary hormonal functions. The study took place in the radiotherapy Department, National Cancer Institute. It included 39 patients with benign brain tumors involving or adjacent to the optic apparatus | ||
| 530 | _aIssued also as CD | ||
| 653 | 4 | _aHypofractionated | |
| 653 | 4 | _aRadiotherapy | |
| 653 | 4 | _aStereotaxy | |
| 700 | 0 |
_aHoda Mohamed Abdulbaki , _eSupervisor |
|
| 700 | 0 |
_aTarek Hamed Shouman , _eSupervisor |
|
| 700 | 0 |
_aWael Abdulhalim Reda , _eSupervisor |
|
| 856 | _uhttp://172.23.153.220/th.pdf | ||
| 905 |
_aNazla _eRevisor |
||
| 905 |
_aSamia _eCataloger |
||
| 942 |
_2ddc _cTH |
||
| 999 |
_c40808 _d40808 |
||